High mRNA expression of LMO4, a BRCA1 downregulator, correlates with better prognosis in erlotinib-treated non-small cell lung cancer (NSCLC) patients (p) with EGFR mutations.
Santiago Viteri Ramirez
No relevant relationships to disclose
Carlota Costa
No relevant relationships to disclose
Ana Gimenez Capitan
No relevant relationships to disclose
Susana Benlloch
No relevant relationships to disclose
Miquel Taron
No relevant relationships to disclose
Jose Javier Sanchez
No relevant relationships to disclose
Amaya Gasco
No relevant relationships to disclose
Alejandro Martinez-Bueno
No relevant relationships to disclose
Niki Karachaliou
No relevant relationships to disclose
Carlos Camps
No relevant relationships to disclose
Teresa Moran
No relevant relationships to disclose
Enric Carcereny Costa
No relevant relationships to disclose
Bartomeu Massuti
No relevant relationships to disclose
Felipe Cardenal
No relevant relationships to disclose
Rut Porta
No relevant relationships to disclose
Joaquim Bosch
No relevant relationships to disclose
Ramon Palmero
No relevant relationships to disclose
Cristina Buges
No relevant relationships to disclose
Rafael Rosell
No relevant relationships to disclose